Boston Scientific Corp. stock outperforms competitors on strong trading day

Boston Scientific Corp. closed 2.98% short of its 52-week high of $107.53, which the company achieved on June 30th. Read More

Bristol Myers Squibb Co. stock outperforms competitors on strong trading day

Bristol Myers Squibb Co. closed 25.25% below its 52-week high of $63.33, which the company reached on March 11th. Read More

Why Boston Scientific (BSX) Outpaced the Stock Market Today

Boston Scientific (BSX) closed at $104.33 in the latest trading session, marking a +1.09% move from the prior day. This change outpaced the S&P 500's 0.14% gain on the day. Elsewhere, the Dow gained 0 ... Read More

Gilead Sciences Inc. stock outperforms competitors on strong trading day

This was the stock's second consecutive day of gains. Gilead Sciences Inc. closed 7.74% below its 52-week high of $119.96, which the company reached on March 10th. Read More

Boston Scientific Corporation (NYSE:BSX) Stock Is Going Strong But ...

Boston Scientific's (NYSE:BSX) stock is up by a considerable 11% over the past three months. However, we wonder if the company's inconsistent financials would have any adverse impact on the ... Read More

Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is ...

Zacks.com users have recently been watching Boston Scientific (BSX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. Read More

What’s Behind The 130% Rise In Boston Scientific Stock? - Forbes

As an aside, see What’s Happening With McDonald’s Stock? Although BSX stock appears fully valued, it's useful to compare Boston Scientific’s competitors on key financial metrics. Read More

Boston Scientific Corp - Reuters

Boston Scientific increased its annual profit forecast on Wednesday, fueled by strong demand for its cardiac implants, but temporarily halted a pivotal heart equipment study citing unexpected events. Read More

Boston Scientific Q2 Earnings: Strong Performance Of Cardiovascular ...

Boston Scientific estimates 2024 adjusted EPS of $2.38-$2.42 compared to prior guidance of $2.29-$2.34 and consensus of $2.33. For the third quarter, the company estimates net sales growth of 13% ... Read More

Boston Scientific (BSX) Outperforms Broader Market: What You ... - Nasdaq

The most recent trading session ended with Boston Scientific (BSX) standing at $91.29, reflecting a +0.66% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which ... Read More